Skip to main content
Diagnostic Medical Systems logo

Diagnostic Medical Systems — Investor Relations & Filings

Ticker · ALDMS ISIN · FR0012202497 LEI · 969500RKTIGCNNIKIN19 PA Manufacturing
Open in API
Filings indexed 232 across all filing types
Latest filing 2022-01-25 Capital/Financing Update
Country FR France
Listing PA ALDMS

About Diagnostic Medical Systems

https://www.dms.com/en/home/

Diagnostic Medical Systems (DMS) specializes in the development, design, and manufacturing of medical imaging systems. The company's core focus is on digital radiology and bone densitometry. Its product portfolio includes radiography and fluoroscopy systems, mobile x-ray units, surgical C-arms, and bone densitometers. DMS is engaged in developing next-generation imaging solutions aimed at improving patient care and personalized medicine. Key development projects include new mobile and surgical imaging equipment and an advanced range of bone densitometers for diagnosing and monitoring pathologies affecting bone mineral density.

Recent filings

Filing Released Lang Actions
Finalisation de l'opération d'apport de la division imagerie médicale du groupe DMS à Asit Biotech
Capital/Financing Update Classification · 99% confidence The document announces the finalization of a major corporate transaction: the contribution of the DMS medical imaging division to ASIT Biotech, resulting in capital increases, a name change (to DMS Imaging SA), and a change in the Board of Directors. This type of significant corporate restructuring, involving capital changes and asset transfers, falls under corporate financing activities. While it details the outcome of a transaction, it is not a standard periodic financial report (10-K, IR, ER). The most fitting category for updates on fundraising, financing activities, or capital structure changes is 'Capital/Financing Update' (CAP). It is a direct announcement of a structural change rather than a general regulatory filing (RNS) or a management report (MDA).
2022-01-25 French
Progression dynamique de 16% de l'activité en 2021
Earnings Release Classification · 100% confidence The document is dated 20/01/2022 and explicitly states it publishes the 'chiffre d'affaires annuel consolidé au titre de l'exercice 2021 clos le 31 décembre 2021' (annual consolidated revenue for the fiscal year 2021 ended December 31, 2021). It provides detailed, non-audited financial figures (revenue breakdown by division and quarter) for the full year 2021. This content aligns perfectly with an Earnings Release (ER), which announces periodical financial results, typically focusing on revenue and key highlights before the full Annual Report (10-K) or detailed financial statements are released. The document is not the comprehensive Annual Report (10-K) as it explicitly states the data is 'non auditées' (unaudited) and the full results are scheduled for publication later (April 29, 2022, according to the agenda). It is too detailed for just a Report Publication Announcement (RPA) and contains the core results, making ER the most appropriate classification. FY 2021
2022-01-20 French
Cession de la division DMS Wellness
M&A Activity Classification · 99% confidence The document announces the divestiture (cession) of the DMS Wellness division by Diagnostic Medical Systems Group (DMS Group) to CES Management SA. This is a significant corporate action related to the company's structure and strategy, specifically involving the sale of a business segment. This type of announcement, detailing a major transaction like a divestiture or acquisition, falls under the category of M&A Activity (TAR). Although it is a short announcement, it contains the core details of the transaction (what was sold, to whom, financial impact for H1 2021, and effective date), making it the primary announcement of the event rather than just a notice that a report is available. Therefore, TAR (M&A Activity) is the most appropriate classification.
2022-01-12 French
Avis de deuxième convocation à l'assemblée générale mixte du 30 décembre 2021
AGM Information Classification · 98% confidence The document is titled "Avis de deuxième convocation à l'assemblée générale mixte du 30 décembre 2021" (Notice of second call for the mixed general meeting of December 30, 2021). It explicitly discusses the scheduling, quorum requirements, and publication of notices related to a shareholder meeting. This content directly relates to the procedures and materials surrounding an Annual General Meeting (AGM). Although it is a notice/announcement, the specific nature of the meeting (AGM) makes 'AGM-R' (AGM Information) the most appropriate classification, as it pertains directly to the meeting itself, rather than just the announcement of a report (RPA) or a general regulatory filing (RNS). Given the context of shareholder meetings, AGM-R is preferred over PSI (Proxy Solicitation) which usually involves the full proxy statement materials requesting votes.
2021-12-20 French
Mise à disposition des documents préparatoires à l'assemble générale mixte du 17 décembre 2021
AGM Information Classification · 98% confidence The document is titled "Mise à disposition des documents préparatoires à l'assemble générale mixte du 17 décembre 2021" (Making available of preparatory documents for the mixed general meeting of December 17, 2021). It explicitly states that the preparatory documents for the General Meeting are available on the company website and provides details about the meeting date, location, and the publication of the notice of meeting. This content is an announcement about the availability of materials for an upcoming shareholder meeting, which aligns perfectly with the definition of AGM Information (AGM-R) or potentially a Report Publication Announcement (RPA) if it were only announcing the release of a specific report. However, since the core subject is the preparation and availability of documents *for* the AGM, AGM-R is the most specific fit. Given the short length (3409 chars) and the focus on making documents available for the AGM, it is a direct communication related to the AGM process.
2021-11-26 French
Reprise du projet de transfert de la cotation des titres DMS Group sur le marché Euronext Growth à Paris
Regulatory Filings Classification · 95% confidence The document discusses the renewal of a project to transfer the listing of DMS Group shares from the regulated market of Euronext Paris to the Euronext Growth market in Paris. It details the rationale, conditions, and consequences of this transfer, and includes a forward-looking financial agenda (Agenda financier 2021) announcing the publication of 2021 annual revenue on January 20, 2022. The core subject is a corporate action (listing transfer) that requires shareholder approval via an upcoming General Meeting (AGM). Since the document is an announcement detailing corporate governance and future shareholder votes related to a significant structural change, and it is not the full financial report (10-K or IR) nor a simple dividend/insider trade notice, it relates most closely to corporate governance and shareholder meeting context. However, the primary focus is the process surrounding the shareholder meeting to approve the transfer, which is a key element of corporate governance and shareholder communication. Given the options, this announcement about the structure and process leading up to a shareholder vote on a major corporate action (transfer of listing) aligns best with the context of shareholder meetings and corporate governance, but it is not the AGM presentation itself (AGM-R) or the proxy materials (PSI). Since it is a formal announcement detailing corporate structure changes and upcoming shareholder votes, it falls under general corporate information. Given the options, and the fact that it is an announcement detailing corporate structure and upcoming shareholder votes, it is a general corporate filing. If the document were solely about the results of the vote, it would be DVA. If it were the proxy materials, it would be PSI. Since it is an announcement about the process and the need for a new resolution at an upcoming meeting, it is a general corporate announcement. The closest fit among the specific codes related to meetings or governance is difficult, but it is not a standard financial report. It is an announcement regarding corporate structure and shareholder action. I will classify it as a Regulatory Filing (RNS) as a general corporate announcement that doesn't fit the highly specific categories like DIV, DIRS, or ER, although it touches upon AGM procedures.
2021-11-12 French

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.